Publications by authors named "Mathias Schulz"

Claim this Profile
E
Enhancing Resilience in Biometric Research: Generation of 3D Synthetic Face Data Using Advanced 3D Character Creation Techniques from High-Fidelity Video Games and Animation.
Florian Erwin Blümel, Mathias Schulz, Ralph Breithaupt, Norbert Jung, Robert Lange

Sensors (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma.
Hsu-Chih Chien, Deborah Morreall, Vikas Patil, Kelli M Rasmussen, Chunyang Li, Mathias Schulz

Future Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US cost-effectiveness of polatuzumab vedotin, bendamustine and rituximab in diffuse large B-cell lymphoma.
Keith A Betts, Per-Olof Thuresson, Federico Felizzi, Ella X Du, Ibou Dieye, Mathias Schulz

J Comp Eff Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase ()-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies.
Shirish Gadgeel, Alice T Shaw, Fabrice Barlesi, Lucio Crino, James Ch Yang, Mathias Schulz

Lung Cancer (Auckl)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K: A master regulator of brain metastasis-promoting macrophages/microglia.
Raquel Blazquez, Darius Wlochowitz, Alexander Wolff, Stefanie Seitz, Astrid Wachter, Mathias Schulz

Glia· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative incidence rates for CNS and non-CNS progression in two phase II studies of alectinib in ALK-positive NSCLC.
Shirish Gadgeel, Alice T Shaw, Fabrice Barlesi, Lucio Crinò, James Chih-Hsin Yang, Mathias Schulz

Br J Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA.
Marco D DiBonaventura, William Wong, Bijal Shah-Manek, Mathias Schulz

Onco Targets Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patella Dislocation in Children and Adolescents.
Sven Höhne, Kristina Gerlach, Lars Irlenbusch, Mathias Schulz, Christian Kunze

Z Orthop Unfall· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of clothes on sphygmomanometric and oscillometric blood pressure measurement.
Max Liebl, Heinrich Holzgreve, Mathias Schulz, Alexander Crispin, Johannes Bogner

Blood Press· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions.
Venkateshwar A Reddy, Atsushi Iwama, Guergana Iotzova, Mathias Schulz, Annika Elsasser

Blood· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis